A method comprising: hydrogenating an indole propionamide compound of formula h ##STR00001## with vitride, to form an aminopropyl indole compound of formula i ##STR00002## wherein m, Ar, R.sup.1 and R.sup.2 are as defined herein. The compounds prepared by the method of the invention are useful as monoamine reuptake inhibitors useful for treatment of CNS indications.